News

IBB

Sideways Action Continues...For Now

Adam Sarhan | Equities.com |

Stocks fell last week, as the major indices continue to move sideways to consolidate their very sharp late-August sell-off. The longer the major indices spend below their important 50


Stocks Rally On Greek Deal

Adam Sarhan | Equities.com |

Stocks rallied nicely last week, helping the tech-heavy Nasdaq 100 breakout of its year-long range and hit a fresh 15-year high. The market was able to breathe a collective sigh of relief when the


Is Biotech Cooling or Gaining a Second Wind?

The Life Sciences Report | Equities.com |

It's all about the fundamentals for Jason Napodano, CFA, of Zacks Investment Research. Revenue and earnings at the big biotechs are signaling investors that the market is still strong, and


Stocks Rally After Fed Meeting

Adam Sarhan | Equities.com |

Stocks rallied last week after the Fed held rates near zero and created the "perfect hedge" by remaining "data-dependent." Yellen told us that she is ready to raise rates


Stocks Fell After Hitting New Highs Last Week

Adam Sarhan | Equities.com |

After all was said and done, underneath the surface, it wasn't a pretty week on Wall Street. On Monday, the benchmark S&P 500 hit a new high for the year, then turned lower after several


Has the Biotech Bull Market Run Too Far?

Guild Investment Management | Equities.com |

When Fed Chair Janet Yellen commented last July about biotechs whose valuations were “substantially stretched,” we took it with a grain of salt. High valuations in the space are


Are ETFs the Best Way to Invest in Biotech Stocks?

The Life Sciences Report | Equities.com |

Andrew McDonald believes investors fundamentally underestimate the risk of investing in companies with drugs in development. To address the inherent hazards, McDonald cofounded LifeSci Advisors,


Puma (PBYI) Shares Quadruple on Trial Results, Biotech Sector Ignites

Joe Goldman | Equities.com |

Shares of Puma Biotechnology (PBYI) rocketed to the moon on Wednesday, gaining over 300% at the intraday high. The stock popped on Puma’s PB272 (neratinib) clinical trials, a drug for the


Inovio Pharmaceuticals (INO) Gains Ground with Markets

Joel Anderson | Equities.com |

Inovio Pharmaceuticals (INO) gained over 6.5 percent on Monday, carrying forward momentum that the stock seemed to be building over the course of Friday’s session, in which Inovio opened


Biotechs, Solar Stocks Lead Nasdaq to Huge Day

Joel Anderson | Equities.com |

Markets were soaring on Monday, particularly among those higher-risk growth stocks that had previously been experience a broad sell-off since the start of March. The positive day wasn’t


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

Blockchain in Digital Identity - Discussion at the EU Parliament

From the recent Blockchain For Europe Summit in Brussels: Panel on Digital Identity